Standard

Commentary on Caulkins et al (2019): Supervised Consumption Sites: A Nuanced Assessment of the Causal Evidence. / May, Tom; Holloway, Katy ; Bennett, Trevor.

2019. 2116.

Research output: Contribution to conference › Paper

Harvard

May, T, Holloway, K & Bennett, T 2019, 'Commentary on Caulkins et al (2019): Supervised Consumption Sites: A Nuanced Assessment of the Causal Evidence', pp. 2116.

APA

May, T., Holloway, K., & Bennett, T. (2019). Commentary on Caulkins et al (2019): Supervised Consumption Sites: A Nuanced Assessment of the Causal Evidence. 2116.

Vancouver

May T, Holloway K, Bennett T. Commentary on Caulkins et al (2019): Supervised Consumption Sites: A Nuanced Assessment of the Causal Evidence. 2019.

Author

May, Tom ; Holloway, Katy ; Bennett, Trevor. / Commentary on Caulkins et al (2019): Supervised Consumption Sites: A Nuanced Assessment of the Causal Evidence. 2121 p.

BibTeX

@conference{3088f8af1b2841e9a324e1d07d79a4a1,
title = "Commentary on Caulkins et al (2019): Supervised Consumption Sites: A Nuanced Assessment of the Causal Evidence",
abstract = "The evidence base for supervised consumption sites is limitedin scope and strength. More evaluation researc h, based onrigorous and robust designs suc h as r andomized controlledtrials, is needed to provide evidence of their effectiveness.",
author = "Tom May and Katy Holloway and Trevor Bennett",
year = "2019",
language = "English",
pages = "2116",

}

RIS

TY - CONF

T1 - Commentary on Caulkins et al (2019): Supervised Consumption Sites: A Nuanced Assessment of the Causal Evidence

AU - May, Tom

AU - Holloway, Katy

AU - Bennett, Trevor

PY - 2019

Y1 - 2019

N2 - The evidence base for supervised consumption sites is limitedin scope and strength. More evaluation researc h, based onrigorous and robust designs suc h as r andomized controlledtrials, is needed to provide evidence of their effectiveness.

AB - The evidence base for supervised consumption sites is limitedin scope and strength. More evaluation researc h, based onrigorous and robust designs suc h as r andomized controlledtrials, is needed to provide evidence of their effectiveness.

M3 - Paper

SP - 2116

ER -

ID: 3789483